Hayat Pharmaceutical Industries Co (AMM:HPIC) Long-Term Debt: JOD3.11 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
79 GF Score
Price JOD3.20
GF Value JOD2.74
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co Long-Term Debt?

Hayat Pharmaceutical Industries Co AMM:HPIC 79 Long-Term Debt is JOD3.11 Mil as of Mar. 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 79/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Hayat Pharmaceutical Industries Co's Long-Term Debt for the quarter that ended in Mar. 2026 was JOD3.11 Mil.

Hayat Pharmaceutical Industries Co's quarterly Long-Term Debt declined from Sep. 2025 (JOD3.12 Mil) to Dec. 2025 (JOD2.48 Mil) but then increased from Dec. 2025 (JOD2.48 Mil) to Mar. 2026 (JOD3.11 Mil).

Hayat Pharmaceutical Industries Co's annual Long-Term Debt increased from Dec. 2023 (JOD1.46 Mil) to Dec. 2024 (JOD3.29 Mil) but then declined from Dec. 2024 (JOD3.29 Mil) to Dec. 2025 (JOD2.48 Mil).

Hayat Pharmaceutical Industries Co  (AMM:HPIC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Hayat Pharmaceutical Industries Co Long-Term Debt Related Terms

Hayat Pharmaceutical Industries Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co Long-Term Debt Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.03 1.46 3.29 2.48

Hayat Pharmaceutical Industries Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.72 3.24 3.12 2.48 3.11
AMM:HPIC
79GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of JOD3.11 Mil mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Long-Term Debt of JOD3.11 Mil as of Mar. 2026.
Is Hayat Pharmaceutical Industries Co's Long-Term Debt too high?
Hayat Pharmaceutical Industries Co's current Long-Term Debt is JOD3.11 Mil. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Long-Term Debt compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's Long-Term Debt of JOD3.11 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Hayat Pharmaceutical Industries Co's current Long-Term Debt is JOD3.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.20 — trading 16.8% above its estimated fair value. The current Long-Term Debt is JOD3.11 Mil. Hayat Pharmaceutical Industries Co's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Long-Term Debt is JOD3.11 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?

Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued. The current stock price of JOD3.20 is trading 16.8% above its estimated GF Value™ of JOD2.74. GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.

Key valuation signals for AMM:HPIC:

  • Long-Term Debt: JOD3.11 Mil
  • GF Value™: JOD2.74 vs. price of JOD3.20 (16.8% above fair value)
  • GF Score™: 79/100 with 9 warning signs

No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
79GF Score

Get the complete analysis for AMM:HPIC

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.20
Price
JOD2.74
GF Value